Ryan Savitz - Net Worth and Insider Trading
Ryan Savitz Net Worth
The estimated net worth of Ryan Savitz is at least $0 dollars as of 2026-08-11. Ryan Savitz is the EVP, CFO & CBO of Dianthus Therapeutics Inc and owns about 0 shares of Dianthus Therapeutics Inc (DNTH) stock worth over $0. Details can be seen in Ryan Savitz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ryan Savitz has not made any transactions after 2026-07-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ryan Savitz
Ryan Savitz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ryan Savitz owns 2 companies in total, including Magenta Therapeutics Inc (MGTA) , and Dianthus Therapeutics Inc (DNTH) .
Click here to see the complete history of Ryan Savitz’s form 4 insider trades.
Insider Ownership Summary of Ryan Savitz
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MGTA | Magenta Therapeutics Inc | 2023-09-11 | CHIEF FINANCIAL OFFICER |
| DNTH | Dianthus Therapeutics Inc | 2026-07-09 | CHIEF FINANCIAL OFFICER |
Ryan Savitz Latest Holdings Summary
Ryan Savitz currently owns a total of 1 stock. Ryan Savitz owns 0 shares of Dianthus Therapeutics Inc (DNTH) as of July 9, 2026, with a value of $0.
Latest Holdings of Ryan Savitz
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics Inc | 2026-07-09 | 0 | 111.80 | 0 |
Holding Weightings of Ryan Savitz
Ryan Savitz Form 4 Trading Tracker
According to the SEC Form 4 filings, Ryan Savitz has made a total of 5 transactions in Dianthus Therapeutics Inc (DNTH) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Dianthus Therapeutics Inc is the sale of 31,249 shares on July 9, 2026, which brought Ryan Savitz around $3 Million.
Insider Trading History of Ryan Savitz
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Ryan Savitz Trading Performance
Ryan Savitz Ownership Network
Ownership Network List of Ryan Savitz
Ownership Network Relation of Ryan Savitz
Ryan Savitz Owned Company Details
What does Magenta Therapeutics Inc do?
Who are the key executives at Magenta Therapeutics Inc?
Ryan Savitz is the CHIEF FINANCIAL OFFICER of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .
Magenta Therapeutics Inc (MGTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Magenta Therapeutics Inc Insider Transactions
Ryan Savitz Mailing Address
Above is the net worth, insider trading, and ownership report for Ryan Savitz. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ryan Savitz's mailing address is: New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
